TreeWAS – Variant ID: rs2484873

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
S42.20 Fracture of upper end of humerus (closed)	0.000	0.956	0.044
S42.2 Fracture of upper end of humerus	0.000	0.966	0.034
S42 Fracture of shoulder and upper arm	0.000	0.974	0.026
S42.21 Fracture of upper end of humerus (open)	0.000	0.976	0.023
S42.4 Fracture of lower end of humerus	0.000	0.978	0.022
S42.0 Fracture of clavicle	0.000	0.978	0.022
S42.8 Fracture of other parts of shoulder and upper arm	0.000	0.980	0.020
S42.40 Fracture of lower end of humerus (closed)	0.000	0.980	0.020
S42.1 Fracture of scapula	0.000	0.981	0.019
S42.3 Fracture of shaft of humerus	0.000	0.981	0.019
S42.00 Fracture of clavicle (closed)	0.000	0.981	0.019
S42.9 Fracture of shoulder girdle, part unspecified	0.000	0.981	0.019
S42.7 Multiple fractures of clavicle, scapula and humerus	0.000	0.981	0.019
N32.3 Diverticulum of bladder	0.000	0.982	0.018
S42.01 Fracture of clavicle (open)	0.000	0.984	0.016
S42.80 Fracture of other parts of shoulder and upper arm (closed)	0.000	0.984	0.015
S42.41 Fracture of lower end of humerus (open)	0.000	0.985	0.015
J98.1 Pulmonary collapse	0.015	0.985	0.000
S42.81 Fracture of other parts of shoulder and upper arm (open)	0.000	0.985	0.014
S42.31 Fracture of shaft of humerus (open)	0.000	0.986	0.014
S42.11 Fracture of scapula (open)	0.000	0.986	0.014
S42.10 Fracture of scapula (closed)	0.000	0.986	0.014
S42.91 Fracture of shoulder girdle, part unspecified (open)	0.000	0.986	0.014
S42.71 Multiple fractures of clavicle, scapula and humerus (open)	0.000	0.986	0.014
S42.30 Fracture of shaft of humerus (closed)	0.000	0.986	0.014
S42.90 Fracture of shoulder girdle, part unspecified (closed)	0.000	0.986	0.013
S42.70 Multiple fractures of clavicle, scapula and humerus (closed)	0.000	0.987	0.013
J98 Other respiratory disorders	0.013	0.987	0.000
S40-S49 Injuries to the shoulder and upper arm	0.000	0.988	0.012
J98.0 Diseases of bronchus, not elsewhere classified	0.012	0.988	0.000
J98.5 Diseases of mediastinum, not elsewhere classified	0.010	0.989	0.000
J98.2 Interstitial emphysema	0.010	0.990	0.000
J98.6 Disorders of diaphragm	0.010	0.990	0.000
J98.9 Respiratory disorder, unspecified	0.010	0.990	0.000
J98.8 Other specified respiratory disorders	0.010	0.990	0.000
J98.3 Compensatory emphysema	0.010	0.990	0.000
S43 Dislocation, sprain and strain of joints and ligaments of shoulder girdle	0.000	0.990	0.010
S45 Injury of blood vessels at shoulder and upper arm level	0.000	0.991	0.009
S41 Open wound of shoulder and upper arm	0.000	0.991	0.009
S48 Traumatic amputation of shoulder and upper arm	0.000	0.991	0.009
S47 Crushing injury of shoulder and upper arm	0.000	0.991	0.009
S46 Injury of muscle and tendon at shoulder and upper arm level	0.000	0.991	0.009
S44 Injury of nerves at shoulder and upper arm level	0.000	0.991	0.009
J95-J99 Other diseases of the respiratory system	0.009	0.991	0.000
S40 Superficial injury of shoulder and upper arm	0.000	0.991	0.009
S49 Other and unspecified injuries of shoulder and upper arm	0.000	0.992	0.008
S43.1 Dislocation of acromioclavicular joint	0.000	0.992	0.008
J99 Respiratory disorders in diseases classified elsewhere	0.008	0.992	0.000
S43.4 Sprain and strain of shoulder joint	0.000	0.992	0.008
J98.4 Other disorders of lung	0.008	0.992	0.000
S43.5 Sprain and strain of acromioclavicular joint	0.000	0.992	0.007
J95 Postprocedural respiratory disorders, not elsewhere classified	0.007	0.993	0.000
S45.9 Injury of unspecified blood vessel at shoulder and upper arm level	0.000	0.993	0.007
S43.3 Dislocation of other and unspecified parts of shoulder girdle	0.000	0.993	0.007
S43.2 Dislocation of sternoclavicular joint	0.000	0.993	0.007
S41.0 Open wound of shoulder	0.000	0.993	0.007
S43.6 Sprain and strain of sternoclavicular joint	0.000	0.993	0.007
S41.8 Open wound of other and unspecified parts of shoulder girdle	0.000	0.993	0.007
S43.7 Sprain and strain of other and unspecified parts of shoulder girdle	0.000	0.993	0.007
S45.8 Injury of other blood vessels at shoulder and upper arm level	0.000	0.993	0.007
S45.7 Injury of multiple blood vessels at shoulder and upper arm level	0.000	0.993	0.007
S45.3 Injury of superficial vein at shoulder and upper arm level	0.000	0.993	0.007
S45.2 Injury of axillary or brachial vein	0.000	0.993	0.007
S45.1 Injury of brachial artery	0.000	0.993	0.007
S45.0 Injury of axillary artery	0.000	0.993	0.007
S46.8 Injury of other muscles and tendons at shoulder and upper arm level	0.000	0.993	0.007
S46.9 Injury of unspecified muscle and tendon at shoulder and upper arm level	0.000	0.993	0.007
S46.1 Injury of muscle and tendon of long head of biceps	0.000	0.993	0.007
J99.8 Respiratory disorders in other diseases classified elsewhere	0.007	0.993	0.000
S40.0 Contusion of shoulder and upper arm	0.000	0.993	0.007
S41.7 Multiple open wounds of shoulder and upper arm	0.000	0.993	0.007
J95.8 Other postprocedural respiratory disorders	0.007	0.993	0.000
S48.9 Traumatic amputation of shoulder and upper arm, level unspecified	0.000	0.993	0.007
S48.1 Traumatic amputation at level between shoulder and elbow	0.000	0.993	0.007
S48.0 Traumatic amputation at shoulder joint	0.000	0.993	0.007
S46.7 Injury of multiple muscles and tendons at shoulder and upper arm level	0.000	0.993	0.007
S44.9 Injury of unspecified nerve at shoulder and upper arm level	0.000	0.993	0.006
S44.8 Injury of other nerves at shoulder and upper arm level	0.000	0.993	0.006
S44.7 Injury of multiple nerves at shoulder and upper arm level	0.000	0.993	0.006
S44.5 Injury of cutaneous sensory nerve at shoulder and upper arm level	0.000	0.993	0.006
S44.4 Injury of musculocutaneous nerve	0.000	0.993	0.006
S44.3 Injury of axillary nerve	0.000	0.993	0.006
S44.1 Injury of median nerve at upper arm level	0.000	0.993	0.006
S44.0 Injury of ulnar nerve at upper arm level	0.000	0.993	0.006
J96 Respiratory failure, not elsewhere classified	0.006	0.993	0.000
S46.3 Injury of muscle and tendon of triceps	0.000	0.993	0.006
N32.9 Bladder disorder, unspecified	0.000	0.993	0.007
S40.7 Multiple superficial injuries of shoulder and upper arm	0.000	0.993	0.006
S44.2 Injury of radial nerve at upper arm level	0.000	0.994	0.006
S46.2 Injury of muscle and tendon of other parts of biceps	0.000	0.994	0.006
N32 Other disorders of bladder	0.000	0.994	0.006
S46.0 Injury of tendon of the rotator cuff of shoulder	0.000	0.994	0.006
A04.8 Other specified bacterial intestinal infections	0.000	0.994	0.006
J99.0 Rheumatoid lung disease	0.006	0.994	0.000
S41.1 Open wound of upper arm	0.000	0.994	0.006
S49.8 Other specified injuries of shoulder and upper arm	0.000	0.994	0.006
S49.7 Multiple injuries of shoulder and upper arm	0.000	0.994	0.006
S40.8 Other superficial injuries of shoulder and upper arm	0.000	0.994	0.006
J99.1 Respiratory disorders in other diffuse connective tissue disorders	0.006	0.994	0.000
S40.9 Superficial injury of shoulder and upper arm, unspecified	0.000	0.994	0.006
S43.0 Dislocation of shoulder joint	0.000	0.994	0.006
J95.2 Acute pulmonary insufficiency following nonthoracic surgery	0.005	0.994	0.000
Y43.3 Other antineoplastic drugs	0.006	0.994	0.000
J95.9 Postprocedural respiratory disorder, unspecified	0.005	0.994	0.000
N31.9 Neuromuscular dysfunction of bladder, unspecified	0.000	0.994	0.006
J95.4 Mendelson's syndrome	0.005	0.994	0.000
J95.3 Chronic pulmonary insufficiency following surgery	0.005	0.994	0.000
J95.1 Acute pulmonary insufficiency following thoracic surgery	0.005	0.994	0.000
R03.0 Elevated blood-pressure reading, without diagnosis of hypertension	0.000	0.995	0.005
D25.9 Leiomyoma of uterus, unspecified	0.000	0.995	0.005
S49.9 Unspecified injury of shoulder and upper arm	0.000	0.995	0.005
N32.2 Vesical fistula, not elsewhere classified	0.000	0.995	0.005
J95.5 Postprocedural subglottic stenosis	0.005	0.995	0.000
J95.0 Tracheostomy malfunction	0.005	0.995	0.000
J96.9 Respiratory failure, unspecified	0.005	0.995	0.000
J96.1 Chronic respiratory failure	0.005	0.995	0.000
J96.0 Acute respiratory failure	0.005	0.995	0.000
N32.4 Rupture of bladder, nontraumatic	0.000	0.995	0.005
Y43 Primarily systemic agents	0.005	0.995	0.000
K65.0 Acute peritonitis	0.000	0.995	0.005
T42.4 Benzodiazepines	0.000	0.995	0.005
N31 Neuromuscular dysfunction of bladder, not elsewhere classified	0.000	0.995	0.005
Y43.0 Antiallergic and antiemetic drugs	0.004	0.996	0.000
J38.2 Nodules of vocal cords	0.000	0.996	0.004
K76.9 Liver disease, unspecified	0.004	0.996	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.996	0.004
N30 Cystitis	0.000	0.996	0.004
I50.0 Congestive heart failure	0.004	0.996	0.000
Y43.1 Antineoplastic antimetabolites	0.004	0.996	0.000
N31.2 Flaccid neuropathic bladder, not elsewhere classified	0.000	0.996	0.004
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.996	0.004
N30.9 Cystitis, unspecified	0.000	0.996	0.004
N30.2 Other chronic cystitis	0.000	0.996	0.004
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.996	0.004
J96.09 Acute respiratory failure; Type unspecified	0.004	0.996	0.000
J96.01 Acute respiratory failure; Type II [hypercapnic]	0.004	0.996	0.000
J96.00 Acute respiratory failure; Type I [hypoxic]	0.004	0.996	0.000
J96.19 Chronic respiratory failure; Type unspecified	0.004	0.996	0.000
J96.11 Chronic respiratory failure; Type II [hypercapnic]	0.004	0.996	0.000
J96.10 Chronic respiratory failure; Type I [hypoxic]	0.004	0.996	0.000
J96.99 Respiratory failure, unspecified; Type unspecified	0.004	0.996	0.000
J96.91 Respiratory failure unspecified; Type II [hypercapnic]	0.004	0.996	0.000
J96.90 Respiratory failure, unspecified; Type I [hypoxic]	0.004	0.996	0.000
N32.1 Vesicointestinal fistula	0.000	0.996	0.004
Y43.4 Immunosuppressive agents	0.004	0.996	0.000
Y43.2 Antineoplastic natural products	0.004	0.996	0.000
N30-N39 Other diseases of urinary system	0.000	0.996	0.004
N30.3 Trigonitis	0.000	0.996	0.004
Y43.9 Primarily systemic agent, unspecified	0.004	0.996	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.004	0.996	0.000
Y43.6 Enzymes, not elsewhere classified	0.004	0.996	0.000
Y43.5 Acidifying and alkalising agents	0.004	0.996	0.000
H02.8 Other specified disorders of eyelid	0.004	0.996	0.000
J38 Diseases of vocal cords and larynx, not elsewhere classified	0.000	0.996	0.004
N31.0 Uninhibited neuropathic bladder, not elsewhere classified	0.000	0.996	0.004
N30.0 Acute cystitis	0.000	0.996	0.004
N31.1 Reflex neuropathic bladder, not elsewhere classified	0.000	0.996	0.003
J38.3 Other diseases of vocal cords	0.000	0.996	0.004
K74.3 Primary biliary cirrhosis	0.003	0.996	0.000
T42.0 Hydantoin derivatives	0.000	0.996	0.003
K74 Fibrosis and cirrhosis of liver	0.003	0.997	0.000
T42.1 Iminostilbenes	0.000	0.997	0.003
N30.4 Irradiation cystitis	0.000	0.997	0.003
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.997	0.003
T42.2 Succinimides and oxazolidinediones	0.000	0.997	0.003
M43.17 Spondylolisthesis (Lumbosacral region)	0.003	0.997	0.000
K74.0 Hepatic fibrosis	0.003	0.997	0.000
J38.6 Stenosis of larynx	0.000	0.997	0.003
J38.5 Laryngeal spasm	0.000	0.997	0.003
T42.3 Barbiturates	0.000	0.997	0.003
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.997	0.003
L08.9 Local infection of skin and subcutaneous tissue, unspecified	0.003	0.997	0.000
N34 Urethritis and urethral syndrome	0.000	0.997	0.003
N30.1 Interstitial cystitis (chronic)	0.000	0.997	0.003
M43.1 Spondylolisthesis	0.003	0.997	0.000
S51.0 Open wound of elbow	0.000	0.997	0.003
K76 Other diseases of liver	0.003	0.997	0.000
J38.0 Paralysis of vocal cords and larynx	0.000	0.997	0.003
J38.4 Oedema of larynx	0.000	0.997	0.003
M35.3 Polymyalgia rheumatica	0.003	0.997	0.000
M43.16 Spondylolisthesis (Lumbar region)	0.003	0.997	0.000
N37 Urethral disorders in diseases classified elsewhere	0.000	0.997	0.003
N33 Bladder disorders in diseases classified elsewhere	0.000	0.997	0.003
J38.7 Other diseases of larynx	0.000	0.997	0.003
F43.2 Adjustment disorders	0.000	0.997	0.003
K74.6 Other and unspecified cirrhosis of liver	0.003	0.997	0.000
K74.5 Biliary cirrhosis, unspecified	0.003	0.997	0.000
J38.1 Polyp of vocal cord and larynx	0.000	0.997	0.003
K74.1 Hepatic sclerosis	0.003	0.997	0.000
H02 Other disorders of eyelid	0.003	0.997	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.997	0.003
H02.5 Other disorders affecting eyelid function	0.003	0.997	0.000
K74.4 Secondary biliary cirrhosis	0.003	0.997	0.000
K74.2 Hepatic fibrosis with hepatic sclerosis	0.003	0.997	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.003	0.997	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.997	0.003
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.997	0.003
O03.4 Incomplete, without complication	0.003	0.997	0.000
K76.8 Other specified diseases of liver	0.003	0.997	0.000
K76.7 Hepatorenal syndrome	0.003	0.997	0.000
N81.6 Rectocele	0.000	0.997	0.003
K76.1 Chronic passive congestion of liver	0.003	0.997	0.000
N34.3 Urethral syndrome, unspecified	0.000	0.997	0.002
M35 Other systemic involvement of connective tissue	0.003	0.997	0.000
N34.2 Other urethritis	0.000	0.997	0.002
M35.0 Sicca syndrome [Sjogren]	0.003	0.997	0.000
N34.1 Nonspecific urethritis	0.000	0.997	0.002
Y46 Antiepileptics and anti-Parkinsonism drugs	0.002	0.997	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.003	0.997	0.000
K70-K77 Diseases of liver	0.003	0.997	0.000
M43.14 Spondylolisthesis (Thoracic region)	0.002	0.997	0.000
Z96.1 Presence of intraocular lens	0.003	0.997	0.000
H02.3 Blepharochalasis	0.003	0.997	0.000
I87.8 Other specified disorders of veins	0.000	0.997	0.002
M35.7 Hypermobility syndrome	0.002	0.997	0.000
Y45.0 Opioids and related analgesics	0.002	0.997	0.000
M43.19 Spondylolisthesis (Site unspecified)	0.002	0.997	0.000
H02.6 Xanthelasma of eyelid	0.002	0.997	0.000
N34.0 Urethral abscess	0.000	0.997	0.002
T46.1 Calcium-channel blockers	0.000	0.997	0.002
M43.18 Spondylolisthesis (Sacral and sacrococcygeal region)	0.002	0.997	0.000
M43.15 Spondylolisthesis (Thoracolumbar region)	0.002	0.997	0.000
M43.13 Spondylolisthesis (Cervicothoracic region)	0.002	0.997	0.000
M43.11 Spondylolisthesis (Occipito-atlanto-axial region)	0.002	0.997	0.000
C34.9 Bronchus or lung, unspecified	0.000	0.997	0.002
K76.5 Hepatic veno-occlusive disease	0.002	0.997	0.000
K76.4 Peliosis hepatis	0.002	0.997	0.000
K76.2 Central haemorrhagic necrosis of liver	0.002	0.997	0.000
M43.10 Spondylolisthesis (Multiple sites in spine)	0.002	0.998	0.000
M43.12 Spondylolisthesis (Cervical region)	0.002	0.998	0.000
I87.2 Venous insufficiency (chronic) (peripheral)	0.000	0.998	0.002
I50 Heart failure	0.002	0.998	0.000
K65 Peritonitis	0.000	0.998	0.002
K72 Hepatic failure, not elsewhere classified	0.002	0.998	0.000
K76.3 Infarction of liver	0.002	0.998	0.000
N33.8 Bladder disorders in other diseases classified elsewhere	0.000	0.998	0.002
N33.0 Tuberculous cystitis	0.000	0.998	0.002
N37.8 Other urethral disorders in diseases classified elsewhere	0.000	0.998	0.002
N37.0 Urethritis in diseases classified elsewhere	0.000	0.998	0.002
S51 Open wound of forearm	0.000	0.998	0.002
R73.9 Hyperglycaemia, unspecified	0.000	0.998	0.002
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
Y57 Other and unspecified drugs and medicaments	0.002	0.998	0.000
I50.9 Heart failure, unspecified	0.002	0.998	0.000
N03.9 Unspecified	0.002	0.998	0.000
M43 Other deforming dorsopathies	0.002	0.998	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.998	0.002
H02.7 Other degenerative disorders of eyelid and periocular area	0.002	0.998	0.000
I27.2 Other secondary pulmonary hypertension	0.002	0.998	0.000
K76.6 Portal hypertension	0.002	0.998	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
Y59 Other and unspecified vaccines and biological substances	0.002	0.998	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.002
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.998	0.002
L08 Other local infections of skin and subcutaneous tissue	0.002	0.998	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.998	0.002
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
S51.9 Open wound of forearm, part unspecified	0.000	0.998	0.002
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
H02.2 Lagophthalmos	0.002	0.998	0.000
M35.1 Other overlap syndromes	0.002	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.998	0.002
Y53 Agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.998	0.000
K72.9 Hepatic failure, unspecified	0.002	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.998	0.002
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.998	0.002
Y58 Bacterial vaccines	0.002	0.998	0.000
K72.0 Acute and subacute hepatic failure	0.002	0.998	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.002
T46.7 Peripheral vasodilators	0.000	0.998	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.998	0.002
Y45.8 Other analgesics and antipyretics	0.002	0.998	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.998	0.002
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.998	0.002
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.998	0.000
H02.4 Ptosis of eyelid	0.002	0.998	0.000
I27.0 Primary pulmonary hypertension	0.002	0.998	0.000
Y46.4 Iminostilbenes	0.002	0.998	0.000
Y46.2 Hydantoin derivatives	0.002	0.998	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.998	0.002
N48.4 Impotence of organic origin	0.002	0.998	0.000
D17.6 Benign lipomatous neoplasm of spermatic cord	0.002	0.998	0.000
K65.8 Other peritonitis	0.000	0.998	0.002
N48.8 Other specified disorders of penis	0.002	0.998	0.000
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.002
O03.9 Complete or unspecified, without complication	0.002	0.998	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.002
Y45.5 4-Aminophenol derivatives	0.002	0.998	0.000
Y45.2 Propionic acid derivatives	0.002	0.998	0.000
Y46.7 Anti-Parkinsonism drugs	0.002	0.998	0.000
M35.8 Other specified systemic involvement of connective tissue	0.002	0.998	0.000
M35.4 Diffuse (eosinophilic) fasciitis	0.002	0.998	0.000
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
O03 Spontaneous abortion	0.002	0.998	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
K81.9 Cholecystitis, unspecified	0.000	0.998	0.002
M35.2 Behcet's disease	0.002	0.998	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.998	0.002
K70 Alcoholic liver disease	0.002	0.998	0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.000	0.998	0.002
M35.9 Systemic involvement of connective tissue, unspecified	0.002	0.998	0.000
M35.6 Relapsing panniculitis [Weber-Christian]	0.002	0.998	0.000
M35.5 Multifocal fibrosclerosis	0.002	0.998	0.000
Y46.6 Other and unspecified antiepileptics	0.002	0.998	0.000
Y57.5 X-ray contrast media	0.002	0.998	0.000
T36 Poisoning by systemic antibiotics	0.000	0.998	0.002
L08.8 Other specified local infections of skin and subcutaneous tissue	0.002	0.998	0.000
Y46.8 Antispasticity drugs	0.002	0.998	0.000
Y46.3 Deoxybarbiturates	0.002	0.998	0.000
Y46.1 Oxazolidinediones	0.002	0.998	0.000
Y46.0 Succinimides	0.002	0.998	0.000
K77 Liver disorders in diseases classified elsewhere	0.002	0.998	0.000
N17.9 Acute renal failure, unspecified	0.002	0.998	0.000
Y44.2 Anticoagulants	0.002	0.998	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
G55.2 Nerve root and plexus compressions in spondylosis	0.002	0.998	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
Y46.5 Valproic acid	0.002	0.998	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
Y54.5 Other diuretics	0.002	0.998	0.000
Y59.3 Immunoglobulin	0.002	0.998	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.002	0.998	0.000
H00-H06 Disorders of eyelid, lacrimal system and orbit	0.002	0.998	0.000
S22.30 Fracture of rib (closed)	0.000	0.998	0.002
C18.9 Colon, unspecified	0.000	0.998	0.002
Y52 Agents primarily affecting the cardiovascular system	0.002	0.998	0.000
H02.0 Entropion and trichiasis of eyelid	0.002	0.998	0.000
T45.2 Vitamins, not elsewhere classified	0.000	0.998	0.002
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
Y57.8 Other drugs and medicaments	0.002	0.998	0.000
F43 Reaction to severe stress, and adjustment disorders	0.000	0.998	0.002
H01.8 Other specified inflammation of eyelid	0.002	0.998	0.000
L08.0 Pyoderma	0.002	0.998	0.000
M43.0 Spondylolysis	0.002	0.998	0.000
S51.7 Multiple open wounds of forearm	0.000	0.998	0.002
T39.0 Salicylates	0.000	0.998	0.002
Y42.7 Androgens and anabolic congeners	0.002	0.998	0.000
Y45.1 Salicylates	0.002	0.998	0.000
Y48.4 Anaesthetic, unspecified	0.002	0.998	0.000
T23 Burn and corrosion of wrist and hand	0.000	0.998	0.002
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.998	0.002
K70.3 Alcoholic cirrhosis of liver	0.002	0.998	0.000
M43.9 Deforming dorsopathy, unspecified	0.002	0.998	0.000
M43.8 Other specified deforming dorsopathies	0.002	0.998	0.000
R73.0 Abnormal glucose tolerance test	0.000	0.998	0.002
T31.0 Burns involving less than 10% of body surface	0.000	0.998	0.002
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
Y42.4 Oral contraceptives	0.002	0.998	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.002	0.998	0.000
Y45.4 Antirheumatics	0.002	0.998	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
K71 Toxic liver disease	0.002	0.998	0.000
N40 Hyperplasia of prostate	0.002	0.998	0.000
M43.6 Torticollis	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.998	0.002
Y44.6 Natural blood and blood products	0.002	0.998	0.000
Y57.6 Other diagnostic agents	0.002	0.998	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.998	0.002
M41.96 Scoliosis, unspecified (Lumbar region)	0.002	0.998	0.000
K72.1 Chronic hepatic failure	0.002	0.998	0.000
M43.5 Other recurrent vertebral subluxation	0.002	0.998	0.000
M43.4 Other recurrent atlantoaxial subluxation	0.002	0.998	0.000
M43.3 Recurrent atlantoaxial subluxation with myelopathy	0.002	0.998	0.000
N31.8 Other neuromuscular dysfunction of bladder	0.000	0.998	0.002
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y57.7 Vitamins, not elsewhere classified	0.002	0.998	0.000
Y57.4 Pharmaceutical excipients	0.002	0.998	0.000
Y57.3 Alcohol deterrents	0.002	0.998	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
Y57.1 Lipotropic drugs	0.002	0.998	0.000
Y57.0 Appetite depressants [anorectics]	0.002	0.998	0.000
I27 Other pulmonary heart diseases	0.002	0.998	0.000
I08.1 Disorders of both mitral and tricuspid valves	0.002	0.998	0.000
K70.1 Alcoholic hepatitis	0.002	0.998	0.000
S79.9 Unspecified injury of hip and thigh	0.000	0.998	0.002
T39.4 Antirheumatics, not elsewhere classified	0.000	0.998	0.002
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.998	0.002
T39.2 Pyrazolone derivatives	0.000	0.998	0.002
T45.4 Iron and its compounds	0.000	0.998	0.002
Y42.2 Antithyroid drugs	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
Y54.4 Loop [high-ceiling] diuretics	0.002	0.998	0.000
I50.1 Left ventricular failure	0.002	0.998	0.000
M43.2 Other fusion of spine	0.002	0.998	0.000
N30.8 Other cystitis	0.000	0.998	0.002
Y42.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.002	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.998	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
Y51.0 Anticholinesterase agents	0.002	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.998	0.000
Y59.2 Protozoal vaccines	0.002	0.998	0.000
Y59.1 Rickettsial vaccines	0.002	0.998	0.000
H01 Other inflammation of eyelid	0.002	0.998	0.000
I87 Other disorders of veins	0.000	0.998	0.002
H53.8 Other visual disturbances	0.000	0.998	0.002
L08.1 Erythrasma	0.002	0.998	0.000
M41.9 Scoliosis, unspecified	0.002	0.998	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.998	0.002
T45.8 Other primarily systemic and haematological agents	0.000	0.998	0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.002
T45.6 Fibrinolysis-affecting drugs	0.000	0.998	0.002
T45.5 Anticoagulants	0.000	0.998	0.002
T45.3 Enzymes, not elsewhere classified	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
Y53.3 Saline and osmotic laxatives	0.002	0.998	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
Y59.0 Viral vaccines	0.002	0.998	0.000
H00 Hordeolum and chalazion	0.002	0.998	0.000
F43.1 Posttraumatic stress disorder	0.000	0.998	0.002
H00.1 Chalazion	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
T37.5 Antiviral drugs	0.000	0.998	0.002
T37.4 Anthelminthics	0.000	0.998	0.002
T37.3 Other antiprotozoal drugs	0.000	0.998	0.002
T37.1 Antimycobacterial drugs	0.000	0.998	0.002
T37.0 Sulphonamides	0.000	0.998	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
T39.1 4-Aminophenol derivatives	0.000	0.998	0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.998	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.998	0.002
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.998	0.000
Y47.4 Bromine compounds	0.002	0.998	0.000
Y47.3 Paraldehyde	0.002	0.998	0.000
Y47.2 Chloral derivatives	0.002	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.998	0.000
Y48.5 Therapeutic gases	0.002	0.998	0.000
Y48.1 Parenteral anaesthetics	0.002	0.998	0.000
Y48.0 Inhaled anaesthetics	0.002	0.998	0.000
Y58.0 BCG vaccine	0.002	0.998	0.000
N48 Other disorders of penis	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
F41.9 Anxiety disorder, unspecified	0.002	0.998	0.000
F43.0 Acute stress reaction	0.000	0.998	0.002
N48.1 Balanoposthitis	0.002	0.998	0.000
T14.0 Superficial injury of unspecified body region	0.000	0.998	0.002
T49.9 Topical agent, unspecified	0.000	0.998	0.002
T49.8 Other topical agents	0.000	0.998	0.002
T49.7 Dental drugs, topically applied	0.000	0.998	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.002
T49.2 Local astringents and local detergents	0.000	0.998	0.002
T49.1 Antipruritics	0.000	0.998	0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.998	0.002
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
T50.1 Loop [high-ceiling] diuretics	0.000	0.998	0.002
Y50.9 Central nervous system stimulant, unspecified	0.002	0.998	0.000
Y50.8 Other central nervous system stimulants	0.002	0.998	0.000
Y50.1 Opioid receptor antagonists	0.002	0.998	0.000
Y50.0 Analeptics	0.002	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
Y53.7 Emetics	0.002	0.998	0.000
Y53.5 Digestants	0.002	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.002	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.998	0.000
Y58.5 Diphtheria vaccine	0.002	0.998	0.000
Y58.4 Tetanus vaccine	0.002	0.998	0.000
Y58.3 Plague vaccine	0.002	0.998	0.000
Y58.2 Cholera vaccine	0.002	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.998	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
G55.3 Nerve root and plexus compressions in other dorsopathies	0.002	0.998	0.000
O03.6 Complete or unspecified, complicated by delayed or excessive haemorrhage	0.002	0.998	0.000
T23.3 Burn of third degree of wrist and hand	0.000	0.998	0.002
T23.2 Burn of second degree of wrist and hand	0.000	0.998	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.002
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.002
T44.0 Anticholinesterase agents	0.000	0.998	0.002
T45.0 Antiallergic and antiemetic drugs	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations